Tovorafenib Impurity 10 | CAS 1028539-33-4 - Request Quote
Tovorafenib Impurity 10
| SZ CAT No: | SZ-T202013 |
| CAS No | 1028539-33-4 |
| Mol.F. | C7H7NO2S |
| Mol.Wt. | 169.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tovorafenib Impurity 10 is chemically 1,1'-(thiazole-2,5-diyl)bis(ethan-1-one). Tovorafenib Impurity 10 is supplied with detailed characterization data compliant with regulatory guideline. Tovorafenib Impurity 10 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tovorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1028539-33-4
Purchase 1028539-33-4
Order 1028539-33-4
Enquire 1028539-33-4
price of 1028539-33-4
1028539-33-4 Supplier
1028539-33-4 Manufacturer
1028539-33-4 Exporter
buy high quality Tovorafenib Impurity 10
Purchase Tovorafenib Impurity 10
Tovorafenib Impurity 10 suppliers
Tovorafenib Impurity 10 manufacturers
Tovorafenib Impurity 10 price
Order Tovorafenib Impurity 10
Enquire Tovorafenib Impurity 10
Tovorafenib Impurity 10 cost
Tovorafenib Impurity 10 Supplier
Tovorafenib Impurity 10 Distributor
Tovorafenib Impurity 10 for Method Validation
Tovorafenib Reference Standard
Tovorafenib Impurity 10 for ANDA Filing
Tovorafenib Impurity 10 for Forced Degradation Studies
Tovorafenib Impurity 10 Identification Standards
Tovorafenib Impurity 10 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


